首页> 外文OA文献 >STUDIES ON THE ROLE OF THE THYMUS IN IMMUNOBIOLOGY : RECONSTITUTION OF IMMUNOLOGIC CAPACITY IN MICE THYMECTOMIZED AT BIRTH
【2h】

STUDIES ON THE ROLE OF THE THYMUS IN IMMUNOBIOLOGY : RECONSTITUTION OF IMMUNOLOGIC CAPACITY IN MICE THYMECTOMIZED AT BIRTH

机译:胸腺在免疫生物学中的作用的研究:出生时经胸腺切除的小鼠免疫功能的重建。

摘要

The immunologic competence of spleen cells of mice, as assessed by their graft versus host capabilities, increases to 35 days of age and beyond. Thymectomy at any point along this continuum of development produces "immunologic arrest;" the peripheral lymphoid tissues of such mice do not show significant increases in activity as the animals mature, nor is there appreciable loss of activity up to 6 months after surgery. Adult spleen cells from mice thymectomized at 1 to 24 hours of age have a greatly reduced ability to induce runt disease. Five million spleen cells from immunologically mature animals will uniformly cause fatal runt disease in neonatal recipients, but this same number of cells from neonatally thymectomized animals produces almost no runt disease. When the dosage of cells from neonatally thymectomized C57Bl mice is increased to 20 million, about half of the A recipients develop runt disease. Thus, the defect is a quantitative one. Spleen cells from neonatally thymectomized mice will induce tolerance of skin grafts from the donor strain. In one recalcitrant strain combination, C57Bl to A, use of spleen cells from neonatally thymectomized donors as the tolerance-inducing inoculum permits survival of the recipients, which usually die with severe runt disease, but does not induce tolerance. Cell free extracts of spleen and thymus tissue, including "promine" of Szent-Gyorgyi et al., did not affect the runting syndrome or the immunologic reactivity of neonatally thymectomized mice. When syngeneic thymic tissue is grafted into neonatally thymectomized mice, or the animals are given viable syngeneic spleen or thymus cells, the majority of the animals escape the early mortality characteristic of this group. Administration of syngeneic spleen cells from adult donors and grafting of syngeneic neonatal thymus provide restoration of homograft immunity and graft versus host reactivity of the peripheral lymphoid tissues in most of the neonatally thymectomized animals. Thymus cells rarely provide significant restoration of these parameters. Allogeneic thymus grafts also restore neonatally thymectomized mice. Such animals are chimeric: the immunologically competent cells of their peripheral lymphoid tissues are chiefly of host origin as determined by the discriminant spleen assay, but in many instances a significant donor component is also demonstrable in this system. These chimeric animals accept skin grafts from both donor and host strains. A degree of reconstitution has also been attained by grafting of allogeneic adult spleen in neonatally thymectomized animals. The discriminant spleen assay indicates that cells of the donor strain predominate in the peripheral lymphoid tissues of such mice.
机译:通过移植物对宿主能力的评估,小鼠脾细胞的免疫能力提高到35天及以后。胸腺切除术在这种发展过程中的任何时候都会产生“免疫性停滞”。这种小鼠的外周淋巴组织在动物成熟后并未表现出明显的活动增加,并且在手术后长达6个月也没有明显的活动丧失。在1至24小时龄经胸腺切除的小鼠的成年脾脏细胞,其诱发矮小疾病的能力大大降低。来自免疫成熟的动物的500万个脾细胞将在新生儿受体中均匀地引起致命的矮小病,但是来自刚被经胸腺切除的动物的相同数量的细胞几乎不会产生任何矮小病。当来自新生儿经胸腺切除的C57B1小鼠的细胞剂量增加至2000万时,大约一半的A受体会发展为矮小病。因此,缺陷是定量的。新生儿经胸腺切除的小鼠的脾细胞将诱导来自供体菌株的皮肤移植物的耐受性。在一种顽固的菌株组合中,C57B1至A,使用来自新生儿经胸腺切除的供体的脾细胞作为诱导耐受性的接种物可以使受体存活,该受体通常死于严重的矮小疾病,但不诱导耐受性。脾脏和胸腺组织的无细胞提取物,包括Szent-Gyorgyi等人的“ promine”,均不影响新生儿胸腺切除小鼠的侏儒综合征或免疫反应。当同系胸腺组织被移植到新生儿经胸腺切除的小鼠中,或给动物以可行的同系脾脏或胸腺细胞时,大多数动物都逃脱了该组的早期死亡特征。来自成年供体的同基因脾细胞的施用和同基因新生儿胸腺的移植提供了在大多数新生儿经胸腺切除的动物中同种异体免疫力的恢复以及外周淋巴组织的移植物抗宿主反应性。胸腺细胞很少提供这些参数的显着恢复。同种异体胸腺移植物还可以恢复新生儿经胸腺切除的小鼠。这样的动物是嵌合的:其外周淋巴组织的免疫学感受态细胞主要是宿主,如通过鉴别脾测定所确定的那样,但是在许多情况下,在该系统中也证明了重要的供体成分。这些嵌合动物接受来自供体和宿主菌株的皮肤移植。通过在新生儿经胸腺切除的动物中移植同种异体成年脾脏,也可以达到一定程度的重构。判别脾分析表明供体菌株的细胞在这类小鼠的外周淋巴组织中占主导地位。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号